Carmen Corregidor-García

4PUBLICATIONS
27CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Systems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 22, 2026
Impact of Budesonide/Glycopyrronium/Formoterol Initiation on Healthcare Resource Utilization and Estimated Associated Costs and Greenhouse Gas Emissions Across COPD Care in Spain (ORESTES* Study).

|Jun 02, 2026
Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study.

|Jan 19, 2026
Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.

Juan Marco Figueira-Gonçalves, Bernardino Alcázar-Navarrete, Raquel Casitas-Mateo

|Sep 22, 2025
Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study.

Bernardino Alcázar-Navarrete, Juan Marco Figueira-Gonçalves, Carmen Corregidor-García

Pageof 1

Frequent Collaborators

4 joint publications

Bernardino Alcázar-Navarrete

4 joint publications

Juan Marco Figueira-Gonçalves

4 joint publications

Eunice Fitas

4 joint publications

Joaquín Sánchez-Covisa